Report overview
Hepatitis C virus (HCV) is a global infectious pathogen that can cause acute and chronic viral hepatitis. The Hepatitis C Virus PCR Diagnostic Kit is a high sensitivity real-time reverse transcriptase (RT) polymerase chain reaction (PCR) test intended for the detection and quantification of HCV specific RNA in human serum and plasma.
This report contains market size and forecasts of Diagnostic Kit for Quantification of Hepatitis C Virus RNA in global, including the following market information:
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Revenue, 2018-2023, 2023-2030, ($ millions)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Sales, 2018-2023, 2023-2030, (K Units)
Global top five Diagnostic Kit for Quantification of Hepatitis C Virus RNA companies in 2022 (%)
The global Diagnostic Kit for Quantification of Hepatitis C Virus RNA market was valued at US$ million in 2022 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period 2023-2030.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million by 2030.
Ultra-sensitive Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Diagnostic Kit for Quantification of Hepatitis C Virus RNA include Abbott, Siemens Healthineers, altona Diagnostics, GeneProof, Roche Diagnostics, 3B BlackBio Biotech India Limited, Biogerm Medical, Liferiver and Rendu Biotechnology, etc. In 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Diagnostic Kit for Quantification of Hepatitis C Virus RNA manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market, by Type, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Segment Percentages, by Type, 2022 (%)
Ultra-sensitive
High Sensitivity
General Sensitivity
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market, by Application, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market, By Region and Country, 2018-2023, 2023-2030 ($ Millions) & (K Units)
Global Diagnostic Kit for Quantification of Hepatitis C Virus RNA Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Diagnostic Kit for Quantification of Hepatitis C Virus RNA revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Diagnostic Kit for Quantification of Hepatitis C Virus RNA revenues share in global market, 2022 (%)
Key companies Diagnostic Kit for Quantification of Hepatitis C Virus RNA sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Diagnostic Kit for Quantification of Hepatitis C Virus RNA sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott
Siemens Healthineers
altona Diagnostics
GeneProof
Roche Diagnostics
3B BlackBio Biotech India Limited
Biogerm Medical
Liferiver
Rendu Biotechnology
Sansure Biotech
Daan Gene
BGI Group
Abiores
ACON Biotech
